The DOI matches its Crossref record; 125 of the 129 references it cites were found in a registry or an index.
The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder
Abstract
Through neuromodulatory influences over fronto-striato-cerebellar circuits, dopamine and noradrenaline play important roles in high-level executive functions often reported to be impaired in attention-deficit/hyperactivity disorder (ADHD). Medications used in the treatment of ADHD (including methylphenidate, dextroamphetamine and atomoxetine) act to increase brain catecholamine levels. However, the precise prefrontal cortical and subcortical mechanisms by which these agents exert their therapeutic effects remain to be fully specified. Herein, we review and discuss the present state of knowledge regarding the roles of dopamine (DA) and noradrenaline in the regulation of corticostriatal circuits, with a focus on the molecular neuroimaging literature (both in ADHD patients and in healthy subjects). Recent positron emission tomography evidence has highlighted the utility of quantifying DA markers, at baseline or following drug administration, in striatal subregions governed by differential cortical connectivity. This approach opens the possibility of characterizing the neurobiological underpinnings of ADHD (and associated cognitive dysfunction) and its treatment by targeting specific neural circuits. It is anticipated that the application of refined and novel positron emission tomography methodology will help to disentangle the overlapping and dissociable contributions of DA and noradrenaline in the prefrontal cortex, thereby aiding our understanding of ADHD and facilitating new treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deficiencies in catecholamines such as NE and DA [75, 79, 80] or dysregulation of such NTs, which are essential for normal brain function, including executive and attentional functions [33], are among the causing physiological alterations that have been reported to explain ADHD development.”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [79]
In the citing paper
“NE-mediated signal transduction speed and duration are affected by NE transporter (NET) protein, as it is involved in NE reuptake [79].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [79]
In the citing paper
“NE, also known as noradrenaline (NA), is an important NT in behaviour control, playing a key role in high-level cognitive processes such as working memory and inhibitory response, which appear to be disrupted in ADHD [79], producing irritability and anxiety [85].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [79]
In the citing paper
“Deficits in certain kinds of attention are relevant to ADHD and other neurological disorders associated with dopamine deficiency (Del Campo et al., 2011).”
From Neuroinflammation as a risk factor for attention deficit hyperactivity disorder (2019) · cites this paper as Del Campo et al., 2011
Citations
Cites
Inhibition and the right inferior frontal cortex
Aron, A. R., Robbins, T. W., & Poldrack, R. A. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.02.010 · Cited by 3,197
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771
Self-citationHaber, S. N., Fudge, J. L., & McFarland, N. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02369.2000 · Cited by 1,610
Modulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593
On the ability to inhibit simple and choice reaction time responses: A model and a method.
Logan, G. D., Cowan, W. B., & Davis, K. A. (1984) · Journal of Experimental Psychology: Human Perception and Performance · doi:10.1037/0096-1523.10.2.276 · Cited by 1,542
The primate basal ganglia: Parallel and integrative networks
Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479
Attention-Deficit/Hyperactivity Disorder: A Selective Overview
Biederman, J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.020 · Cited by 1,343
The role of the right inferior frontal gyrus: inhibition and attentional control
Hampshire, A., Chamberlain, S. R., Monti, M. M., Duncan, J., & Owen, A. M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.109 · Cited by 1,327
Self-citationMolina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23d0 · Cited by 1,182
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Flagged first, then by citations
4 of the 129 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Draganski, 2008, Evidence for segregated and integrative connectivity patterns in the human basal ganglia, J Neurosci, 28, 7143, 10.1523/JNEUROSCI.1486-08.2008 · DOI
Cited by
Sorted by citations
Items 101–200 of 685
Amyloidosis and cardiac involvement.
Cacoub, P., Axler, O., de Zuttere, D., Hausfater, P., Amoura, Z., Walter, S., Wechsler, B., Godeau, P., & Pietté, J. C. (2000) · PubMed · Cited by 54
A dimensional approach to modeling symptoms of neuropsychiatric disorders in the marmoset monkey
Oikonomidis, L., Santangelo, A. M., Shiba, Y., Clarke, F. H., Robbins, T. W., & Roberts, A. C. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22446 · Cited by 54
Self-citationSchwerdtfeger, R. M. H., Alahyane, N., Brien, D. C., Coe, B. C., Stroman, P. W., & Munoz, D. P. (2012) · NeuroImage Clinical · doi:10.1016/j.nicl.2012.10.006 · Cited by 58
Sahakian, B. J., & Morein‐Zamir, S. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00004-8 · Cited by 55
Mayer, J. S., Hees, K., Medda, J., Grimm, O., Asherson, P., Bellina, M., Colla, M., Ibáñez, P., Koch, E., Martinez-Nicolas, A., et al. (2018) · Trials · doi:10.1186/s13063-017-2426-1 · Cited by 48
Guadarrama-Flores, B., Rodrı́guez-Monroy, M., Cruz‐Sosa, F., García‐Carmona, F., & Gandía‐Herrero, F. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00065 · Cited by 53
Visual Network Asymmetry and Default Mode Network Function in ADHD: An fMRI Study
Hale, T. S., Kane, A. M., Kaminsky, O., Tung, K. L., Wiley, J. F., McGough, J. J., Loo, S. K., & Kaplan, J. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00081 · Cited by 50
Mansouri, M. T., Naghizadeh, B., López‐Larrubia, P., & Cauli, O. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.009 · Cited by 55
Pineda, E., Jentsch, J. D., Shin, D. H., Griesbach, G. S., Sankar, R., & Mazarati, A. M. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.10.004 · Cited by 51
Kratz, O., Studer, P., Baack, J., Malcherek, S., Erbe, K., Moll, G. H., & Heinrich, H. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.008 · Cited by 55
Alkam, T., Mamiya, T., Kimura, N., Yoshida, A., Kihara, D., Tsunoda, Y., Aoyama, Y., Hiramatsu, M., Kim, H.-C., & Nabeshima, T. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4591-z · Cited by 50
The Development of the Mesoprefrontal Dopaminergic System in Health and Disease
Islam, K. U. S., Meli, N., & Blaess, S. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.746582 · Cited by 55
Modulation of Social Influence by Methylphenidate
Campbell-Meiklejohn, D. K., Simonsen, A., Jensen, M., Wohlert, V., Gjerløff, T., Scheel‐Krüger, J., Møller, A., Frith, C., & Roepstorff, A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.337 · Cited by 54
Groom, M. J., Liddle, E. B., Scerif, G., Liddle, P. F., Batty, M. J., Liotti, M., & Hollis, C. P. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12069 · Cited by 48
Clemow, D. B. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_426 · Cited by 50
Shang, C., Yan, C., Lin, H., Tseng, W. I., Castellanos, F. X., & Gau, S. S. (2016) · Psychological Medicine · doi:10.1017/s0033291716001938 · Cited by 48
Wiers, C. E., Lohoff, F. W., Lee, J., Muench, C., Freeman, C. R., Zehra, A., Marenco, S., Lipska, B. K., Auluck, P. K., Feng, N., et al. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14067 · Cited by 51
Krajeski, R. N., Macey-Dare, A. D. B., van Heusden, F., Ebrahimjee, F., & Ellender, T. J. (2019) · The Journal of Physiology · doi:10.1113/jp278416 · Cited by 46
Unravelling the effects of methylphenidate on the dopaminergic and noradrenergic functional circuits
Dipasquale, O., Martins, D., Sethi, A., Veronese, M., Hesse, S., Rullmann, M., Sabri, O., Turkheimer, F., Harrison, N. A., Mehta, M. A., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0724-x · Cited by 46
Li, D., Tsai, C., Hsiao, R. C.-J., Chen, Y., & Yen, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084503 · Cited by 48
Lange, M., Froc, C., Grunwald, H. A., Norton, W., & Bally‐Cuif, L. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.02.010 · Cited by 47
Zhang, N., Gao, M., Yu, J., Zhang, Q., Wang, W., Zhou, C., Liu, L., Sun, T., Liao, X., & Wang, J. (2022) · Brain and Behavior · doi:10.1002/brb3.2748 · Cited by 48
Purkinje cell dopaminergic inputs to astrocytes regulate cerebellar-dependent behavior
Li, C., Saliba, N. B., Martin, H., Losurdo, N. A., Kolahdouzan, K., Siddiqui, R., Medeiros, D., & Li, W. (2023) · Nature Communications · doi:10.1038/s41467-023-37319-w · Cited by 46
Sengupta, S. M., Grizenko, N., Thakur, G. A., Bellingham, J., DeGuzman, R., ROBINSON, S. O., Ter-Stepanian, M., Poloskia, A., Shaheen, S. ‐., Fortier, M., et al. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110073 · Cited by 46
Preller, K. H., Ingold, N., Hulka, L. M., Vonmoos, M., Jenni, D., Baumgartner, M. R., Vollenweider, F. X., & Quednow, B. B. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.003 · Cited by 47
The role of the locus coeruleus in shaping adaptive cortical melodies
Wainstein, G., Müller, E. J., Taylor, N. L., Munn, B., & Shine, J. M. (2022) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2022.03.006 · Cited by 47
Silberstein, R. B., Pipingas, A., Farrow, M., Lévy, F., & Stough, C. K. K. (2016) · Brain and Behavior · doi:10.1002/brb3.582 · Cited by 51
Clock genes, ADHD and aggression
Mogavero, F., Jager, A., & Glennon, J. C. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.002 · Cited by 44
Noradrenaline tracks emotional modulation of attention in human amygdala
Bang, D., Luo, Y., Barbosa, L. S., Batten, S. R., Hadj-Amar, B., Twomey, T., Melville, N., White, J. P., Torres, A. S., Celaya, X., et al. (2023) · Current Biology · doi:10.1016/j.cub.2023.09.074 · Cited by 43
Davis, C., Cohen, A., Davids, M., & Rabindranath, A. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00047 · Cited by 48
Kwak, M., Kim, S. H., Kim, H. H., Tanpure, R. S., Kim, J. I., Jeon, B., & Park, H. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1238005 · Cited by 42
Humby, T., Eddy, J. B., Good, M. A., Reichelt, A. C., & Wilkinson, L. S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.112 · Cited by 44
Sigurdardottir, H., Kranz, G., Rami-Mark, C., James, G. M., Vanicek, T., Gryglewski, G., Berroterán-Infante, N., Kautzky, A., Hienert, M., Traub-Weidinger, T., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0461-x · Cited by 34
Prevalence of attention deficit hyperactivity disorder symptoms in narcolepsy: a systematic review
Kim, J., Lee, G.-H., Sung, S. M., Jung, D. S., & Pak, K. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.07.022 · Cited by 43
Schnorr, I., Siegl, A., Luckhardt, S., Wenz, S., Friedrichsen, H., Jomaa, H. E., Steinmann, A., Kilencz, T., Arteaga-Henríquez, G., Ramos-Sayalero, C., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-023-02729-3 · Cited by 40
The dopaminergic system and Alzheimer’s disease
Zhang, Y., Liang, Y., & Gu, Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00230 · Cited by 47
Rommel, A., Halperin, J. M., Mill, J. S., Asherson, P. J., & Kuntsi, J. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.05.018 · Cited by 40
Neurochemicals, Behaviours and Psychiatric Perspectives of Neurological Diseases
Choudhury, A., Sahu, T., Ramanujam, P. L., Banerjee, A. K., Chakraborty, I., Arun Kumar, R., & Arora, N. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000361 · Cited by 41
Rezaei, M., Kamarzard, T. S., & Razavi, M. N. (2018) · Annals of Applied Sport Science · doi:10.29252/aassjournal.6.4.17 · Cited by 39
Hearne, L. J., Lin, H., Sanz‐Leon, P., Tseng, W. I., Gau, S. S., Roberts, J. A., & Cocchi, L. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0554-6 · Cited by 39
Fatseas, M., Alexandre, J., Vénisse, J.-L., Romo, L., Valleur, M., Magalon, D., Chéreau, I., Luquiens, A., Guilleux, A., Groupe, J. E. U., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.03.028 · Cited by 40
Estrada‐Plana, V., Esquerda, M., Mangues, R., March‐Llanes, J., & Moya-Higueras, J. (2019) · Games for Health Journal · doi:10.1089/g4h.2018.0051 · Cited by 46
Mariggiò, M. A., Palumbi, R., Vinella, A., Laterza, R., Petruzzelli, M. G., Peschechera, A., Gabellone, A., Gentile, O., Vincenti, A., & Margari, L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.705890 · Cited by 40
Greasing the wheels of managing overweight and obesity with omega-3 fatty acids
Golub, N. I., Geba, D.-A., Mousa, S. A., Williams, G. C., & Block, R. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.09.016 · Cited by 40
Gilsbach, S., Neufang, S., Scherag, S., Vloet, T. D., Fink, G. R., Herpertz‐Dahlmann, B., & Konrad, K. (2012) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2012.05.001 · Cited by 38
Yang, Z., Kelly, C. A. M., Castellanos, F. X., Leon, T. L., Milham, M. P., & Adler, L. A. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0243 · Cited by 37
Sterley, T.-L., Howells, F. M., & Russell, V. A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.10.023 · Cited by 37
Mass spectrometry for the detection of potential psychiatric biomarkers
Wetie, A. G. N., Sokolowska, I., Wormwood, K. L., Beglinger, K. M., Michel, T. M., Thome, J., Darie, C. C., & Woods, A. G. (2013) · Journal of Molecular Psychiatry · doi:10.1186/2049-9256-1-8 · Cited by 35
Sethi, A., Voon, V., Critchley, H. D., Cercignani, M., & Harrison, N. A. (2018) · Brain · doi:10.1093/brain/awy048 · Cited by 36
Keehn, B., Kadlaskar, G., Bergmann, S., McNally Keehn, R., & Francis, A. (2021) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2021.716447 · Cited by 35
Serotonin and Dopamine Blood Levels in ADHD-Like Dogs
González‐Martínez, Á., de Miguel, S. M., Graña, N., Costas, X., & Diéguez, F. J. (2023) · Animals · doi:10.3390/ani13061037 · Cited by 38
Noradrenergic neuromodulation in ageing and disease
Krohn, F., Lancini, E., Ludwig, M., Leiman, M., Guruprasath, G., Haag, L., Panczyszyn, J., Düzel, E., Hämmerer, D., & Betts, M. J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105311 · Cited by 41
Inflammation, Dopaminergic Brain and Bilirubin
Jayanti, S. D., Verde, C. D., Tiribelli, C., & Gazzin, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411478 · Cited by 39
Cobos, J. P. D. L., Siñol, N., Pérez, V., & Trujols, J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12045 · Cited by 38
Bubl, E., Dörr, M., Riedel, A., Ebert, D., Philipsen, A., Bach, M., & van Elst, L. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118271 · Cited by 34
Tseng, C.-T., Gaulding, S. J., Dancel, C. L., & Thorn, C. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-00976-2 · Cited by 35
Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges
Fan, H., Chiang, K.-L., Chang, K., Chen, C., & Tsai, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065270 · Cited by 39
New emerging bio-catalysts design in biotransformations
Palomo, J. M., & Filice, M. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.12.010 · Cited by 34
Mindfulness-Based Cognitive Therapy and the Adult ADHD Brain: A Neuropsychotherapeutic Perspective
Bachmann, K., Lam, A. P., & Philipsen, A. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00117 · Cited by 42
Abramov, D. M., Cunha, C. Q., Galhanone, P. R., Alvim, R. J., Mayer, A., & Lazarev, V. V. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219472 · Cited by 37
Bergwerff, C. E., Luman, M., Blom, H., & Oosterlaan, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151100 · Cited by 34
Thakur, G. A., Sengupta, S. M., Grizenko, N., Choudhry, Z., & Joober, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049616 · Cited by 36
A mouse model of autism implicates endosome pH in the regulation of presynaptic calcium entry
Ullman, J. C., Yang, J., Sullivan, M., Bendor, J., Levy, J. M., Pham, E., Silm, K., Seifikar, H., Sohal, V. S., Nicoll, R. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02716-5 · Cited by 32
Impact of Motivation on Selected Aspects of Attention in Children with ADHD
Skalski‐Bednarz, S. B., Pochwatko, G., & Balas, R. (2020) · Child Psychiatry & Human Development · doi:10.1007/s10578-020-01042-0 · Cited by 44
Mouri, A., Hoshino, Y., Narusawa, S., Ikegami, K., Mizoguchi, H., Murata, Y., Yoshimura, T., & Nabeshima, T. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.05.021 · Cited by 33
Ioannidis, K., Chamberlain, S. R., & Müller, U. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114541014 · Cited by 36
Adler, L. A., Clemow, D. B., Williams, D. W., & Durell, T. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104175 · Cited by 32
Inattention, impulsive action, and subjective response to d-amphetamine
Weafer, J. J., & de Wit, H. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.05.021 · Cited by 34
Fitzpatrick, C. M., Runegaard, A. H., Christiansen, S. H., Hansen, N. W., Jørgensen, S. H., McGirr, J. C., Ajenjo, A. D. D., Sørensen, A. T., Perrier, J., Petersen, A., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.12.004 · Cited by 33
Idrees, I., Bellato, A., Cortese, S., & Groom, M. J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104968 · Cited by 37
Agay, N., Yechiam, E., Carmel, Z., & Levkovitz, Y. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000076 · Cited by 32
Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine
Schulz, K. P., Bedard, A., Fan, J., Hildebrandt, T., Stein, M. A., Ivanov, I., Halperin, J. M., & Newcorn, J. H. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2017.04.005 · Cited by 32
Homma, D., Katoh, S., Tokuoka, H., & Ichinose, H. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12287 · Cited by 32
Zieger, E., & Schubert, M. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.001 · Cited by 32
Buck, J. M., O’Neill, H. C., & Stitzel, J. A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.08.003 · Cited by 29
Taurines, R., Grünblatt, E., Schecklmann, M., Schwenck, C., Albantakis, L., Reefschläger, L., Walitza, S., Renner, T., Gerlach, M., Thome, J., et al. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.600297 · Cited by 34
Wunderli, M. D., Vonmoos, M., Niedecker, S. M., Hulka, L. M., Preller, K. H., Baumgartner, M. R., Kræmer, T., Seifritz, E., Schaub, M. P., Eich‐Höchli, D., et al. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.03.026 · Cited by 32
Prenatal nicotine sex-dependently alters adolescent dopamine system development
Dwyer, J. B., Cardenas, A., Franke, R. M., Chen, Y., Bai, Y., Belluzzi, J. D., Lotfipour, S., & Leslie, F. M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0640-1 · Cited by 30
Exploration of a novel virtual environment improves memory consolidation in ADHD
Baumann, V., Birnbaum, T., Breitling-Ziegler, C., Tegelbeckers, J., Dambacher, J., Edelmann, E., Bergado-Acosta, J. R., Flechtner, H., & Krauel, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-78222-4 · Cited by 33
Alam, S. I., Jo, M. G., Park, T. J., Ullah, R., Ahmad, S., Rehman, S. U., & Kim, M. O. (2021) · Biomedicines · doi:10.3390/biomedicines9010047 · Cited by 30
Timple, J. M. V., Magalhães, L. G., Rezende, K. C. S., Pereira, A. C., Cunha, W. R., Silva, M. L. A. E., Mortensen, O. V., & Fontana, A. C. K. (2013) · Journal of Natural Products · doi:10.1021/np400452n · Cited by 29
O’Hara, V. M., Curran, J. L., & Browne, N. T. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00410-0 · Cited by 31
Effect of gut microbiota early in life on aggressive behavior in mice
Watanabe, N., Mikami, K., Hata, T., Kimoto, K., Nishino, R., Akama, F., Yamamoto, K., Sudo, N., Koga, Y., & Matsumoto, H. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.01.005 · Cited by 28
Brain functional connectivity abnormalities in attention‐deficit hyperactivity disorder
Silberstein, R. B., Pipingas, A., Farrow, M., Lévy, F., Stough, C. K. K., & Camfield, D. (2016) · Brain and Behavior · doi:10.1002/brb3.583 · Cited by 27
Xie, Z., Liang, H., Miao, M., Wang, Z., Chen, Y., Yang, L., Zhou, Y., Cao, W., & Yuan, W. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.2c06535 · Cited by 30
Chen, X., & Zhang, Y. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.379042 · Cited by 29
Caballero-Puntiverio, M., Fitzpatrick, C. M., Woldbye, D. P. D., & Andreasen, J. T. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116684339 · Cited by 29
Grazioli, S., Mauri, M., Crippa, A., Maggioni, E., Molteni, M., Brambilla, P., & Nobile, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.100 · Cited by 27
Pharmacological treatment of cognitive deficits in nondementing mental health disorders
Robbins, T. W. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.3/trobbins · Cited by 30
Novel non-stimulants rescue hyperactive phenotype in an adgrl3.1 mutant zebrafish model of ADHD
Sveinsdóttir, H. S., Christensen, C., Thorsteinsson, H. S., Lavalou, P., Parker, M. O., Shkumatava, A., Norton, W., Andriambeloson, E., Wagner, S., & Karlsson, K. Æ. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01505-z · Cited by 28
Groenman, A. P., Greven, C. U., van Donkelaar, M. M. J., Schellekens, A., van Hulzen, K. J. E., Rommelse, N. N. J., Hartman, C. A., Hoekstra, P. J., Luman, M., Franke, B., et al. (2015) · Addiction Biology · doi:10.1111/adb.12230 · Cited by 27
Humby, T., & Wilkinson, L. S. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.06.006 · Cited by 29
Ivanov, I., Liu, X., Schulz, K. P., Fan, J., London, E. D., Friston, K. J., Halperin, J. M., & Newcorn, J. H. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.08.004 · Cited by 27
Schabram, I., Henkel, K., Shali, S. M., Dietrich, C., Schmaljohann, J., Winz, O., Prinz, S., Rademacher, L., Neumaier, B., Felzen, M., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1560-14.2014 · Cited by 27
Schreiner, M. J., Lázaro, M. T., Jalbrzikowski, M., & Bearden, C. E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.09.012 · Cited by 28
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26
Morello, F., Võikar, V., Parkkinen, P., Panhelainen, A. E., Rosenholm, M., Makkonen, A., Rantamäki, T., Piepponen, P. T., Aitta‐aho, T., & Partanen, J. M. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01033-8 · Cited by 25
Miguel, P. M., Deniz, B. F., Deckmann, I., Confortim, H. D., Diaz, R., Laureano, D. P., Silveira, P. P., & Pereira, L. O. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1273551 · Cited by 26
Integrated analysis of the critical region 5p15.3–p15.2 associated with cri-du-chat syndrome
Corrêa, T., Feltes, B. C., & Riegel, M. (2019) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2018-0173 · Cited by 26
Manjur, S. M., Díaz, L. R. M., Lee, I., Skuse, D., Thompson, D., Marmolejo‐Ramos, F., Constable, P. A., & Posada-Quintero, H. F. (2024) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-024-06290-w · Cited by 29
Metadata
- Authors
- del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W.
- Affiliations
- University of Cambridge (GB)
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 69
- Issue
- 12
- Pages
- e145-e157
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2025431637
- Cited by
- 685
- References
- 129
- Citations by year
- 2026: 61 · 2025: 65 · 2024: 57 · 2023: 49 · 2022: 51 · 2021: 46 · 2020: 43 · 2019: 41 · 2018: 36 · 2017: 31 · 2016: 32 · 2015: 45 · 2014: 44 · 2013: 32 · 2012: 43
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- Gates Cambridge Trust
- Wellcome Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- attention deficit hyperactivity disorder, dopamine, norepinephrine, catecholamines, executive function, corticostriatal circuits, prefrontal cortex, striatum, positron emission tomography, methylphenidate, d-amphetamine, atomoxetine, neuromodulation, ADHD treatment
- MeSH terms
- Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Brain Mapping, Cerebral Cortex, Corpus Striatum, Dopamine, Humans, Neural Pathways, Norepinephrine, Prefrontal Cortex, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
